|
KIAA1147 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.40969999907048E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.0158999997365E-07 |
| Normal-vs-Stage2 |
3.369300E-04 |
| Normal-vs-Stage3 |
1.22020005210999E-09 |
| Normal-vs-Stage4 |
2.06400000002382E-06 |
| Stage1-vs-Stage2 |
9.537600E-01 |
| Stage1-vs-Stage3 |
1.552290E-02 |
| Stage1-vs-Stage4 |
6.131600E-02 |
| Stage2-vs-Stage3 |
7.109600E-02 |
| Stage2-vs-Stage4 |
2.087800E-01 |
| Stage3-vs-Stage4 |
8.720200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.08439999891542E-08 |
| Normal-vs-AfricanAmerican |
1.72419999999729E-06 |
| Normal-vs-Asian |
3.92430000000221E-05 |
| Caucasian-vs-AfricanAmerican |
8.256800E-01 |
| Caucasian-vs-Asian |
2.303400E-01 |
| AfricanAmerican-vs-Asian |
2.500200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.35740000350992E-08 |
| Normal-vs-Female |
2.221900E-04 |
| Male-vs-Female |
1.490600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.6655000000001E-05 |
| Normal-vs-Extreme_Weight |
8.04259999709345E-08 |
| Normal-vs-Obese |
6.75040000008842E-07 |
| Normal-vs-Extreme_Obese |
2.419500E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.235600E-01 |
| Normal_Weight-vs-Obese |
8.638000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.061800E-01 |
| Extreme_Weight-vs-Obese |
4.817800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.513200E-01 |
| Obese-vs-Extreme_Obese |
6.179000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.247740E-04 |
| Normal-vs-Age(41-60Yrs) |
3.44789999995321E-06 |
| Normal-vs-Age(61-80Yrs) |
1.01510000405369E-08 |
| Normal-vs-Age(81-100Yrs) |
3.460000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.517200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.620000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.774000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.181420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.708600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.235800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.77480000047071E-07 |
| Normal-VS-Type2 PRCC |
1.07760000922497E-09 |
| Normal-VS-KIRP CIMP |
7.022900E-03 |
| Normal-VS-Unclassified PRCC |
5.609500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.518500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.088000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.493600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.622180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.258370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.004600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26465504735052E-12 |
| Normal-vs-N1 |
5.41040000023862E-07 |
| Normal-vs-N2 |
8.818800E-04 |
| N0-vs-N1 |
4.307800E-01 |
| N0-vs-N2 |
7.926800E-01 |
| N1-vs-N2 |
5.963600E-01 |
|
|
